Abstract

The BLK and CD40 loci have been associated with Kawasaki disease (KD) in two genome-wide association studies (GWAS) conducted in a Taiwanese population of Han Chinese ancestry (Taiwanese) and in Japanese cohorts. Here we build on these findings with replication studies of the BLK and CD40 loci in populations of Korean and European descent. The BLK region was significantly associated with KD susceptibility in both populations. Within the BLK gene the rs2736340-located linkage disequilibrium (LD ) comprising the promoter and first intron was strongly associated with KD, with the combined results of Asian studies including Taiwanese, Japanese, and Korean populations (2,539 KD patients and 7,021 controls) providing very compelling evidence of association (rs2736340, OR = 1.498, 1.354–1.657; P = 4.74×10−31). We determined the percentage of B cells present in the peripheral blood mononuclear cell (PBMC) population and the expression of BLK in the peripheral blood leukocytes (leukocytes) of KD patients during the acute and convalescent stages. The percentage of B cells in the PBMC population and the expression of BLK in leukocytes were induced in patients in the acute stage of KD. In B cell lines derived from KD patients, and in purified B cells from KD patients obtained during the acute stage, those with the risk allele of rs2736340 expressed significantly lower levels of BLK. These results suggest that peripheral B cells play a pathogenic role during the acute stage of KD. Decreased BLK expression in peripheral blood B cells may alter B cell function and predispose individuals to KD. These associative data suggest a role for B cells during acute KD. Understanding the functional implications may facilitate the development of B cell-mediated therapy for KD.

Highlights

  • Kawasaki disease (KD) (OMIM 300530) is an acute, self-limited vasculitis predominantly affecting infants and young children [1]

  • We observed that B Lymphoid Tyrosine Kinase (BLK) expression was significantly induced in leukocytes at the acute stage of KD in patients and that expression was reduced during the convalescence stage, which was correlated with the change of B cell population in peripheral blood mononuclear cell (PBMC)

  • We demonstrated that the risk variant of rs2736340 in BLK was associated with regulation of the expression of BLK and activation of B cell receptor stimulation in the transformed B-cell lines established from KD patients

Read more

Summary

Introduction

Kawasaki disease (KD) (OMIM 300530) is an acute, self-limited vasculitis predominantly affecting infants and young children [1]. The disease is characterised by prolonged fever and at least four out of five diagnostic features: polymorphous skin rash; bilateral conjunctival injection; erythema of the oral mucosa, lips, and tongue; erythema and red skin on the palms of the hands and the soles of the feet; and cervical lymphadenopathy. Coronary artery aneurysms develop in 15–25% of untreated patients, making KD the leading cause of acquired heart disease in children in developed countries [2]. Treatment with intravenous immunoglobulin (IVIG) abrogates the inflammation in approximately 80% of affected individuals and reduces the incidence of coronary artery lesions to ,5%. Coronary artery aneurysms may lead to ischaemic heart disease, myocardial infarction, and sudden death. Clinical and epidemiological findings suggest that an infectious agent triggers an inflammatory response that leads to host immune dysregulation in genetically predisposed individuals; no pathogen has been isolated, and the aetiology of KD remains unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call